Cargando…

Acute interstitial nephritis after sequential ipilumumab - nivolumab therapy of metastatic melanoma

BACKGROUND: The anti-Programmed Death receptor 1 (anti-PD-1) antibodies nivolumab and pembrolizumab are new treatments in metastatic melanoma. Immunotherapies are best known to be responsible for thrombotic microangiopathy. However, immune interstitial nephritis has been described in a patient treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bottlaender, Lea, Breton, Anne-Laure, de Laforcade, Louis, Dijoud, Frederique, Thomas, Luc, Dalle, Stephane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514510/ https://www.ncbi.nlm.nih.gov/pubmed/28716106 http://dx.doi.org/10.1186/s40425-017-0261-2

Ejemplares similares

Bilateral uveitis and macular edema induced by Nivolumab: a case report
por: Theillac, Claire, et al.
Publicado: (2017)

Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy
por: Faieta, Antonio, et al.
Publicado: (2021)

Association of Acute Interstitial Nephritis with Nivolumab in Renal Cell Carcinoma: A Case Report
por: Noto-Kadou-Kaza, Befa, et al.
Publicado: (2021)

Severe acute interstitial nephritis after combination immune-checkpoint inhibitor therapy for metastatic melanoma
por: Murakami, Naoka, et al.
Publicado: (2016)

Severe acute interstitial nephritis after combination immune-checkpoint inhibitor therapy for metastatic melanoma
por: Murakami, Naoka, et al.
Publicado: (2016)

Sequential Therapy with Nivolumab Followed by Ipilimumab Induces Complete Response in Metastatic Melanoma of the Lung but with Severe Hepatotoxicities
por: Furudate, Sadanori, et al.
Publicado: (2016)

Acute Interstitial Nephritis With Karyomegalic Epithelial Cells After Nivolumab Treatment—Two Case Reports
por: Ryuzaki, Masaki, et al.
Publicado: (2019)

Nivolumab plus ipilimumab induced endocrinopathy and acute interstitial nephritis in metastatic sarcomatoid renal-cell carcinoma: A case report and review of literature
por: Hino, Christopher, et al.
Publicado: (2022)

Acute Interstitial Nephritis in a Patient with Non-Small Cell Lung Cancer under Immunotherapy with Nivolumab
por: Georgianos, Panagiotis I., et al.
Publicado: (2019)

Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal Melanoma
por: Aedo-Lopez, Veronica, et al.
Publicado: (2022)

Concomitant Anti-GBM Glomerulonephritis and Acute Interstitial Nephritis Following Programmed Death Receptor-1 Blockade With Nivolumab
por: Tani, Takashi, et al.
Publicado: (2022)

First-line treatment of metastatic melanoma: role of nivolumab
por: Force, Jeremy, et al.
Publicado: (2017)

Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma
por: Diab, Adi, et al.
Publicado: (2021)

Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor
por: Escandon, Julia, et al.
Publicado: (2017)

The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma
por: Marco, Tucci, et al.
Publicado: (2019)

Acute granulomatous interstitial nephritis in a patient with metastatic melanoma on targeted therapy with dabrafenib and trametinib—A case report
por: Krelle, Anna, et al.
Publicado: (2021)

Treatment of NRAS-mutated advanced or metastatic melanoma: rationale, current trials and evidence to date
por: Boespflug, Amélie, et al.
Publicado: (2017)

ACUTE INTERSTITIAL NEPHRITIS
por: Councilman, W. T.
Publicado: (1898)

Granulomatous interstitial nephritis
por: Shah, Shivani, et al.
Publicado: (2015)

Metrorrhagia in Interstitial Nephritis
por: Cumston, Charles Greene
Publicado: (1905)

Chronic Interstitial Nephritis
por: Gillis, J. A.
Publicado: (1896)

Impact of Bone Metastases on Patients with Renal Cell Carcinoma or Melanoma Treated with Combotherapy Ipilimumab Plus Nivolumab
por: Pham, Félix, et al.
Publicado: (2022)

Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma
por: Han, Nanumi, et al.
Publicado: (2018)

Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma
por: Asher, Nethanel, et al.
Publicado: (2020)

CORRIGENDUM to The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma
Publicado: (2019)

Complications of sequential immunotherapy in metastatic melanoma
por: Bufalino, Shams, et al.
Publicado: (2015)

Acute interstitial nephritis with Prothionamide
por: Asnake, Molla, et al.
Publicado: (2022)

Chronic Interstitial Nephritis in Childhood
Publicado: (1897)

The Latest Option: Nivolumab and Relatlimab in Advanced Melanoma
por: Albrecht, Lea Jessica, et al.
Publicado: (2023)

Nivolumab: Interstitial pneumonitis: case report
Publicado: (2020)

Subset analysis of the safety and efficacy of nivolumab in elderly patients with metastatic melanoma
por: Freeman, Morganna, et al.
Publicado: (2015)

Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic Melanoma
por: Rouvinov, Keren, et al.
Publicado: (2019)

Acute hypophysitis secondary to nivolumab immunotherapy in a patient with metastatic melanoma
por: Kuru, Sugabramya, et al.
Publicado: (2017)

Complete regression of metastatic malignant melanoma endoscopically after nivolumab administration
por: Ryu, Dae Gon, et al.
Publicado: (2021)

Secondary Adrenal Insufficiency in a Patient with Metastatic Melanoma Treated with Nivolumab
por: Omata, Wataru, et al.
Publicado: (2022)

Ipilimumab and Nivolumab-Induced Colitis in a Patient With Recurrent Metastatic Melanoma
por: Moein, Hamid-Reza, et al.
Publicado: (2021)

Long Term Administration of Nivolumab for Metastatic Melanoma: A Case Report
por: Oprea, Adela-Raluca, et al.
Publicado: (2022)

Regression of Multiple Melanocytic Nevi in Two Patients on Nivolumab for Metastatic Melanoma
por: Baeza-Hernández, Gloria, et al.
Publicado: (2023)

Severe Gastritis Due to Nivolumab Treatment of a Metastatic Melanoma Patient
por: Samonis, George, et al.
Publicado: (2022)

The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab
por: Mallardo, Domenico, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n8m33j70829b8r6eaa573imdd4